AI Terminal

MODULE: AI_ANALYST
Interactive Q&A, Risk Assessment, Summarization
MODULE: DATA_EXTRACT
Excel Export, XBRL Parsing, Table Digitization
MODULE: PEER_COMP
Sector Benchmarking, Sentiment Analysis
SYSTEM ACCESS LOCKED
Authenticate / Register Log In

Fresenius SE & Co. KGaA

Earnings Release May 4, 2011

166_rns_2011-05-04_7e3150e9-24db-488c-b594-00e4c6e84c0b.html

Earnings Release

Open in Viewer

Opens in native device viewer

News Details

Ad-hoc | 4 May 2011 07:08

Fresenius SE & Co. KGaA: Excellent start into 2011 − Fresenius raises 2011 sales and earnings outlook

Fresenius SE & Co. KGaA / Key word(s): Quarter Results

04.05.2011 07:08

Dissemination of an Ad hoc announcement according to § 15 WpHG, transmitted
by DGAP - a company of EquityStory AG.
The issuer is solely responsible for the content of this announcement.


Excellent start into 2011 − Fresenius raises 2011 sales and earnings
outlook

Group sales increased by 9% (7% in constant currency) to EUR3,962 million
(Q1 2010: EUR3,643 million). Organic sales growth was 6%. Acquisitions
contributed 1%, currency translation effects a further 2%.

Group EBIT increased by 15% (13% in constant currency) to EUR575 million
(Q1 2010: EUR501 million). The EBIT margin increased to 14.5% (Q1 2010:
13.8%).

Group net income* increased by 43% (39% in constant currency) to EUR170
million (Q1 2010: EUR119 million). Earnings per ordinary share increased by
41% to EUR1.05. Group net income** (including special items) reached EUR128
million or EUR0.79 per ordinary share.

Fresenius Group raises its sales and earnings guidance for 2011. The
company now expects sales growth of 7% to 8% and net income growth* of 12%
to 16%, both in constant currency. Previously, the company expected sales
growth of >=7% and net income growth* of 8% to 12%, both in constant
currency.

* Net income attributable to Fresenius SE & Co. KGaA; adjusted for the
effects of mark-to-market accounting of the Mandatory Exchangeable Bonds
(MEB) and the Contingent Value Rights (CVR) related to the acquisition of
APP Pharmaceuticals. Both are non-cash items.

** Net income attributable to Fresenius SE & Co. KGaA

(Financial statements according to U.S. GAAP)

Fresenius SE & Co. KGaA,
represented by Fresenius Management SE,
Board of Management

Bad Homburg v.d.H., May 4, 2011
End of note

04.05.2011 DGAP's Distribution Services include Regulatory Announcements,
Financial/Corporate News and Press Releases.
Media archive at www.dgap-medientreff.de and www.dgap.de


Language: English
Company: Fresenius SE & Co. KGaA
Else-Kröner-Straße 1
61352 Bad Homburg v.d.H.
Deutschland
Phone: +49 (0)6172 608-2485
Fax: +49 (0)6172 608-2488
E-mail: [email protected]
Internet: www.fresenius.com
ISIN: DE0005785604
WKN: 578560
Indices: DAX
Listed: Regulierter Markt in Düsseldorf, Frankfurt (Prime Standard),
München; Freiverkehr in Berlin, Hamburg, Hannover, Stuttgart;
Terminbörse EUREX

End of Announcement DGAP News-Service


Talk to a Data Expert

Have a question? We'll get back to you promptly.